查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1821532

2025年全球抗菌药物敏感性测试市场报告

Antimicrobial Susceptibility Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年抗菌药物敏感性测试市场规模将强劲成长，到2029年将达到57.6亿美元，复合年增长率为5.5%。预测期内的成长归因于抗药性感染疾病的流行、医疗基础设施的完善、对药物研发的日益重视以及可支配收入的提高。预测期内的主要趋势包括自动化和机器人技术、人工智慧和机器学习、多路復用、远端医疗整合以及快速气喘方法。

未来五年5.5%的成长预测比我们先前的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会扰乱美国的临床微生物学，因为这会增加从美国和加拿大进口的自动化抗菌药物敏感性测试 (AST) 平台和培养基的成本，从而可能导致检测结果延迟，并增加医院实验室的营运成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响可能更为广泛。

感染疾病的全球蔓延正在推动抗菌药物敏感性测试市场的成长。感染疾病是由细菌、病毒、真菌和寄生虫等生物引起的。细菌感染会导致细菌性肺炎、结核病以及天花和爱滋病等病毒引起的其他疾病。例如，美国国家公共卫生机构疾病管制与预防中心在2024年3月报告称，在2023年已知出生地的9,573例结核病病例中，有7,259例（76%）来自美国境外，比2022年报告的6,177例增加了18%。因此，感染疾病盛行率的上升正在推动抗菌药物敏感性测试市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球抗菌药物敏感性测试：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球抗菌药物敏感性测试市场：成长率分析
  • 全球抗菌药物敏感性测试市场表现：规模与成长，2019-2024
  • 全球抗菌药物敏感性测试市场预测：规模与成长，2024-2029年，2034年
  • 全球抗菌药物敏感性测试：总目标市场（TAM）

第六章 市场细分

  • 全球抗菌药物敏感性测试市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 抗菌测试
  • 抗真菌测试
  • 抗寄生虫测试
  • 其他类型
  • 全球抗菌药物敏感性测试市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 手动抗菌药敏测试产品
  • 自动化实验室设备
  • 耗材
  • 全球抗菌药物敏感性测试市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 诊断
  • 药物研发
  • 流行病学
  • 其他用途
  • 全球抗菌药物敏感性测试市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊断中心
  • 製药和生物技术公司
  • 研究和学术机构
  • 临床研究组织（CRO）
  • 全球抗菌药物敏感性测试市场：按抗菌测试类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 纸锭扩散法
  • 肉汤稀释法
  • E-测试方法
  • 自动化系统
  • 全球抗菌药物敏感性测试市场：按抗真菌测试类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 肉汤稀释法
  • 琼脂纸锭扩散法
  • E-测试方法
  • 比色法
  • 全球抗菌药物敏感性测试市场：按抗寄生虫测试类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 试管内药敏试验
  • 显微镜
  • 分子方法
  • 全球抗菌药物敏感性测试市场：按类型（其他）细分、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 结核分枝桿菌药敏试验
  • 生物膜敏感性测试
  • 联合抗菌试验

第七章 区域和国家分析

  • 全球抗菌药物敏感性测试市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球抗菌药物敏感性测试市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 抗菌药物敏感性测试市场：竞争格局
  • 抗菌药物敏感性测试市场：公司简介
    • BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Accelerate Diagnostics Inc.
  • Hi-Media Laboratories
  • Creative Diagnostics
  • Merck KGaA
  • Roche Diagnostics Limited
  • Alifax Holding SpA
  • Synbiosis Ltd.
  • Zhuhai DL Biotech Co. Ltd.
  • Mast Group Ltd.
  • ELITechGroup
  • Genefluidics Inc.
  • Condalab
  • QuantaMatrix Inc.
  • Bruker Corporation
  • Eurofins Scientific SE

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年抗菌药物敏感性测试市场：提供新机会的国家
  • 2029年抗菌药物敏感性测试市场：细分市场带来新机会
  • 2029年抗菌药物敏感性测试市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21011u

Antimicrobial susceptibility testing (AST) is a laboratory procedure conducted by clinical professionals to determine the most effective antimicrobial specimen for individual patients. The market for antimicrobial susceptibility testing involves the sales of such testing services provided by entities, including organizations, sole traders, and partnerships, engaged in laboratory services.

The primary types of AST procedures include antibacterial testing, antifungal testing, antiparasitic testing, and others. Antifungal susceptibility testing assesses the ability of a specific organism to grow in vitro in the presence of a particular drug. AST products utilized in testing encompass manual antimicrobial susceptibility testing products, automated laboratory instruments, and other consumables. These products find applications in diagnostics, drug discovery and development, and epidemiology. Antimicrobial susceptibility testing is employed by hospitals, diagnostic centers, pharmaceutical and biotechnology companies, research and academic institutes, as well as clinical research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The antimicrobial susceptibility testing market research report is one of a series of new reports from The Business Research Company that provides antimicrobial susceptibility testing market statistics, including antimicrobial susceptibility testing industry global market size, regional shares, competitors with an antimicrobial susceptibility testing market share, detailed antimicrobial susceptibility testing market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial susceptibility testing industry. This antimicrobial susceptibility testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antimicrobial susceptibility testing market size has grown strongly in recent years. It will grow from $4.36 billion in 2024 to $4.65 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rise in healthcare expenditure, aging population, awareness and education, regulatory support, economic growth.

The antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing prevalence of drug-resistant infections, rise in healthcare infrastructure, growing emphasis on drug discovery, rise in disposable income. Major trends in the forecast period include automation and robotics, ai and machine learning, multiplexing, telemedicine integration, rapid ast methods.

The forecast of 5.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. clinical microbiology by increasing costs for automated Antimicrobial Susceptibility Testing(AST) platforms and culture media imported from Italy and Canada, potentially delaying test results and raising hospital lab operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of infectious diseases worldwide has fueled the growth of the antimicrobial susceptibility testing market. Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and parasites. Bacterial infections can lead to conditions like bacterial pneumonia, tuberculosis, and other diseases caused by viruses, such as smallpox and AIDS. For instance, in March 2024, the Centers for Disease Control and Prevention, a U.S.-based national public health agency, reported that in 2023, out of 9,573 TB cases with known birth origins, 7,259 (76%) were among non-U.S.-born individuals, marking an 18% increase from the 6,177 cases reported in 2022. Therefore, the rising incidence of infectious diseases is propelling the growth of the antimicrobial susceptibility testing market.

The mounting prevalence of chronic diseases is expected to be a significant factor fueling the growth of the antimicrobial susceptibility testing market. Chronic illnesses, which are enduring and often incurable conditions necessitating ongoing medical management, render individuals more vulnerable to various infections. Antimicrobial susceptibility testing plays a crucial role in identifying the specific pathogens responsible for these infections and determining the most effective antibiotics against them. For example, a report by the Centers for Disease Control and Prevention (CDC) in July 2022 highlighted that a considerable proportion of the American population grapples with chronic diseases, thereby increasing susceptibility to infections such as chronic lung diseases, heart disease, stroke, and diabetes. This rise in chronic conditions is a driving force behind the market's growth.

A notable trend emerging in the antimicrobial susceptibility testing market is the adoption of rapid testing methods aimed at preventing antibiotic misuse and ensuring more effective treatments. Various techniques, such as Fluorescence in situ hybridization (FISH) and QuickFish technology (OpGen), utilize probes targeting RNA to rapidly identify and test microbial susceptibility. For instance, the antimicrobial susceptibility testing system developed by Genefluidics Inc uses an electrochemical biosensor to measure bacterial growth by quantifying 16s rRNA molecules, ensuring swift and accurate testing. This emphasis on rapid testing methods stands as a key trend in the evolution of the antimicrobial susceptibility testing market, catering to the pressing need for timely and accurate analysis to guide effective treatment strategies.

Major companies in the antimicrobial susceptibility testing market are advancing through the development of innovative products like the First Point-of-Care (POC) Testing System. This groundbreaking system is designed to identify the presence or absence of bacteria and evaluate the efficacy of antimicrobials by utilizing urine samples from patients suspected of having urinary tract infections (UTIs). The introduction of this system marks a significant stride in the realm of antimicrobial susceptibility testing (AST) technologies. Its primary advantage lies in expediting the commencement of targeted antimicrobial therapy for patients diagnosed with infections. For example, in June 2023, Sysmex Corporation, a Japan-based company specializing in manufacturing reagents and equipment for clinical tests, introduced a rapid antimicrobial susceptibility testing system. This innovative system employs a unique and proprietary microfluidic technology, delivering AST results in as little as 30 minutes from the initiation of the measurement process. This is a substantial reduction compared to the several days typically required for conventional AST methods. The system's swift and accurate results revolutionize the efficiency and timeliness of treatment initiation, catering to the urgent needs of patients requiring targeted antimicrobial therapy.

Major companies operating in the antimicrobial susceptibility testing market include BioMerieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Hi-Media Laboratories, Creative Diagnostics, Merck KGaA, Roche Diagnostics Limited, Alifax Holding S.p.A., Synbiosis Ltd., Zhuhai DL Biotech Co. Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., Condalab, QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Micromax Technologies, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S, VWR International LLC, ZeptoMetrix Corporation

North America was the largest region in the antimicrobial susceptibility testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antimicrobial susceptibility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The antimicrobial susceptibility testing (AST) market includes revenues earned by dilution susceptibility tests and disc diffusion susceptibility tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antimicrobial Susceptibility Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antimicrobial susceptibility testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antimicrobial susceptibility testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antimicrobial susceptibility testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Antibacterial Testing; Antifungal Testing; Antiparasitic Testing; Other Types
  • 2) By Products: Manual Antimicrobial Susceptibility Testing Products; Automated Laboratory Instruments; Consumables
  • 3) By Application: Diagnostics; Drug Discovery and Development; Epidemiology; Other Applications
  • 4) By End User: Hospitals And Diagnostic Centers; Pharmaceutical And Biotechnology Companies; Research And Academic Institutes; Clinical Research Organizations (CROs)
  • Subsegments:
  • 1) By Antibacterial Testing: Disk Diffusion Method; Broth Dilution Method; E-Test Method; Automated Systems
  • 2) By Antifungal Testing: Broth Dilution Method; Agar Disk Diffusion Method; E-Test Method; Colorimetric Methods
  • 3) By Antiparasitic Testing: In vitro Susceptibility Testing; Microscopic Examination; Molecular Methods
  • 4) By Other Types: Mycobacterial Susceptibility Testing; Biofilm Susceptibility Testing; Combination Antimicrobial Testing
  • Companies Mentioned: BioMerieux SA; Becton Dickinson and Company; Thermo Fisher Scientific Inc.; Danaher Corporation; Bio-Rad Laboratories Inc.; Accelerate Diagnostics Inc.; Hi-Media Laboratories; Creative Diagnostics; Merck KGaA; Roche Diagnostics Limited; Alifax Holding S.p.A.; Synbiosis Ltd.; Zhuhai DL Biotech Co. Ltd.; Mast Group Ltd.; ELITechGroup; Genefluidics Inc.; Condalab; QuantaMatrix Inc.; Bruker Corporation; Eurofins Scientific SE; Liofilchem s.r.l.; Hardy Diagnostics; Micromax Technologies; Bioanalyse GmbH; Lab M Limited; Microbiologics Inc.; Quidel Corporation; R-Biopharm AG; SSI Diagnostica A/S; VWR International LLC; ZeptoMetrix Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antimicrobial Susceptibility Testing Market Characteristics

3. Antimicrobial Susceptibility Testing Market Trends And Strategies

4. Antimicrobial Susceptibility Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Antimicrobial Susceptibility Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Antimicrobial Susceptibility Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Antimicrobial Susceptibility Testing Market Growth Rate Analysis
  • 5.4. Global Antimicrobial Susceptibility Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Antimicrobial Susceptibility Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Antimicrobial Susceptibility Testing Total Addressable Market (TAM)

6. Antimicrobial Susceptibility Testing Market Segmentation

  • 6.1. Global Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibacterial Testing
  • Antifungal Testing
  • Antiparasitic Testing
  • Other Types
  • 6.2. Global Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Antimicrobial Susceptibility Testing Products
  • Automated Laboratory Instruments
  • Consumables
  • 6.3. Global Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Drug Discovery and Development
  • Epidemiology
  • Other Applications
  • 6.4. Global Antimicrobial Susceptibility Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Centers
  • Pharmaceutical And Biotechnology Companies
  • Research And Academic Institutes
  • Clinical Research Organizations (CROs)
  • 6.5. Global Antimicrobial Susceptibility Testing Market, Sub-Segmentation Of Antibacterial Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disk Diffusion Method
  • Broth Dilution Method
  • E-Test Method
  • Automated Systems
  • 6.6. Global Antimicrobial Susceptibility Testing Market, Sub-Segmentation Of Antifungal Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Broth Dilution Method
  • Agar Disk Diffusion Method
  • E-Test Method
  • Colorimetric Methods
  • 6.7. Global Antimicrobial Susceptibility Testing Market, Sub-Segmentation Of Antiparasitic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In vitro Susceptibility Testing
  • Microscopic Examination
  • Molecular Methods
  • 6.8. Global Antimicrobial Susceptibility Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mycobacterial Susceptibility Testing
  • Biofilm Susceptibility Testing
  • Combination Antimicrobial Testing

7. Antimicrobial Susceptibility Testing Market Regional And Country Analysis

  • 7.1. Global Antimicrobial Susceptibility Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Antimicrobial Susceptibility Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antimicrobial Susceptibility Testing Market

  • 8.1. Asia-Pacific Antimicrobial Susceptibility Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antimicrobial Susceptibility Testing Market

  • 9.1. China Antimicrobial Susceptibility Testing Market Overview
  • 9.2. China Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antimicrobial Susceptibility Testing Market

  • 10.1. India Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antimicrobial Susceptibility Testing Market

  • 11.1. Japan Antimicrobial Susceptibility Testing Market Overview
  • 11.2. Japan Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antimicrobial Susceptibility Testing Market

  • 12.1. Australia Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antimicrobial Susceptibility Testing Market

  • 13.1. Indonesia Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antimicrobial Susceptibility Testing Market

  • 14.1. South Korea Antimicrobial Susceptibility Testing Market Overview
  • 14.2. South Korea Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antimicrobial Susceptibility Testing Market

  • 15.1. Western Europe Antimicrobial Susceptibility Testing Market Overview
  • 15.2. Western Europe Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antimicrobial Susceptibility Testing Market

  • 16.1. UK Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antimicrobial Susceptibility Testing Market

  • 17.1. Germany Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antimicrobial Susceptibility Testing Market

  • 18.1. France Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antimicrobial Susceptibility Testing Market

  • 19.1. Italy Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antimicrobial Susceptibility Testing Market

  • 20.1. Spain Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antimicrobial Susceptibility Testing Market

  • 21.1. Eastern Europe Antimicrobial Susceptibility Testing Market Overview
  • 21.2. Eastern Europe Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antimicrobial Susceptibility Testing Market

  • 22.1. Russia Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antimicrobial Susceptibility Testing Market

  • 23.1. North America Antimicrobial Susceptibility Testing Market Overview
  • 23.2. North America Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antimicrobial Susceptibility Testing Market

  • 24.1. USA Antimicrobial Susceptibility Testing Market Overview
  • 24.2. USA Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antimicrobial Susceptibility Testing Market

  • 25.1. Canada Antimicrobial Susceptibility Testing Market Overview
  • 25.2. Canada Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antimicrobial Susceptibility Testing Market

  • 26.1. South America Antimicrobial Susceptibility Testing Market Overview
  • 26.2. South America Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antimicrobial Susceptibility Testing Market

  • 27.1. Brazil Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antimicrobial Susceptibility Testing Market

  • 28.1. Middle East Antimicrobial Susceptibility Testing Market Overview
  • 28.2. Middle East Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antimicrobial Susceptibility Testing Market

  • 29.1. Africa Antimicrobial Susceptibility Testing Market Overview
  • 29.2. Africa Antimicrobial Susceptibility Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Antimicrobial Susceptibility Testing Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Antimicrobial Susceptibility Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antimicrobial Susceptibility Testing Market Competitive Landscape And Company Profiles

  • 30.1. Antimicrobial Susceptibility Testing Market Competitive Landscape
  • 30.2. Antimicrobial Susceptibility Testing Market Company Profiles
    • 30.2.1. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Antimicrobial Susceptibility Testing Market Other Major And Innovative Companies

  • 31.1. Accelerate Diagnostics Inc.
  • 31.2. Hi-Media Laboratories
  • 31.3. Creative Diagnostics
  • 31.4. Merck KGaA
  • 31.5. Roche Diagnostics Limited
  • 31.6. Alifax Holding S.p.A.
  • 31.7. Synbiosis Ltd.
  • 31.8. Zhuhai DL Biotech Co. Ltd.
  • 31.9. Mast Group Ltd.
  • 31.10. ELITechGroup
  • 31.11. Genefluidics Inc.
  • 31.12. Condalab
  • 31.13. QuantaMatrix Inc.
  • 31.14. Bruker Corporation
  • 31.15. Eurofins Scientific SE

32. Global Antimicrobial Susceptibility Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antimicrobial Susceptibility Testing Market

34. Recent Developments In The Antimicrobial Susceptibility Testing Market

35. Antimicrobial Susceptibility Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Antimicrobial Susceptibility Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Antimicrobial Susceptibility Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Antimicrobial Susceptibility Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer